The peripheral Foxp3 
T cells can be readily converted to Foxp3 
Introduction
Regulatory T cells play an important role in self-tolerance, acquired tolerance, and immunological homeostasis [1, 2] . There are multiple types of immune regulatory T cells, including Tr1 cells, natural killer T cells, CD8 + T cells and CD4 + CD25 + Foxp3 + cells [3] . CD4 + CD25 + Foxp3 + cells (referred to as Treg) are the predominant regulatory T cells. Treg, which are defined by their expression of Foxp3, are broadly subdivided into nTreg and iTreg [4] . nTreg are generated by the interactions between thymic T cell receptors (TCRs) with a high affinity for MHC class II ligands in the thymus. These cells help to maintain tolerance to self-antigens to prevent autoimmunity and to regulate immune responses by raising activation thresholds. Induced Treg cells are potentially derived from various conditions outside the thymus, a phenomenon that has been supported by numerous in vivo studies [4] .
Although it is clear that iTreg are converted from activated T effector cells in the periphery, the origin of activated T effector cells is unclear. Previous in vivo evidence has suggested that iTreg are derived from conventional CD4 +
CD25
-T cells in the periphery [5] [6] [7] . Further in vitro studies supported this notion, as iTreg can be efficiently differentiated from purified CD4 + CD25 -T cells via TGF-β stimulation [8] . Recently, other studies reported that of the CD4 +
-T cells, only naive CD4 + T cells (Tn) but not memory CD4 + T cells (Tm) are able to differentiate into iTreg in vitro in both mouse and human models [9] [10] [11] [12] . It is generally accepted that iTreg are converted from activated naive CD4 + CD25 -T cells in vivo. Although naive CD4 + CD25 --T cells can be converted into iTreg by TGF-β, the ability of memory CD4 + CD25
--T cells to differentiate into iTreg remains controversial. One report has shown that human Foxp3 + iTreg are derived from the rapid turnover of peripheral memory CD4 + Foxp3 -T cells in vivo, and another found that mouse Th2 memory T cells can be efficiently converted into Foxp3 + iTreg in vitro using a differentiation protocol [13, 14] . Additionally, human skin-derived memory Th cells can be converted into Foxp3 + iTreg with a suitable manipulation [15] . These studies revealed the possibility that memory CD4 
Materials and Methods

Ethics Statement
Healthy human peripheral blood was obtained from the Blood Centre of Anhui Province (Hefei, China). Peripheral blood was obtained from chronic HBV-infected and healthy women at the Centre for Disease Control and Prevention in Hefei, China. Ethical approval to use these samples was obtained from the Ethics Committee of the University of Science and Technology of China (Permit Number: USTCACUC1201011). In accordance with the Declaration of Helsinki and the Institutional Review Board of the University of Science and Technology of China, all participants provided written informed consent, which was obtained before enrolment in the study.
The study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals. A GFP-Foxp3 fusion protein was created by introducing a bicistronic enhanced GFP reporter gene into the endogenous Foxp3 loci of B6 mice (foxp3 gfp ), as previously reported [19] . These knock-in mice were bred and maintained at Harvard Medical School in Boston. All protocols involving animal work were approved by the Animal Care and Use Committee at Harvard Medical School (Permit Number: 004848). All surgery was performed under anaesthesia, and all efforts were made to minimize animal suffering.
Cell purification
Peripheral blood mononuclear cells (PBMCs) were prepared by centrifugation over Ficoll-Hypaque gradients and then stained with APC- Cy7-anti-CD4, PE-anti-CD25, FITC-anti-CD45RA, and APC-anti-CD45RO (or APC-Cy7-anti-CD4, PEanti-CD25, FITC-anti-CD62L, APC-anti-CD45RO, PE-Cy7-anti-CCR7) 
T cells in vitro
Peripheral blood mononuclear cells (PBMCs) were prepared by centrifugation over Ficoll-Hypaque gradients from healthy human peripheral blood. Naive, memory, central memory and effector memory human CD4 T cells were sorted from the prepared PBMCs. The FACS-sorted human CD4 T cells were stimulated in vitro (5×10 4 cells/well) with plate-bound anti-CD3 (5 μg/ml; BD Bioscience) and soluble anti-CD28 (1 μg/ml; BD Bioscience) for 1-7 days in the presence of recombinant human TGF-β (5 ng/ml; R&D) and IL-2 (100 U/ml; Peptech) or not. The induction of 
Flow cytometric analysis
For intracellular Foxp3 and CTLA-4 staining, cultured cells were resuspended and labelled with the fluorochromeconjugated specific mAbs against surface markers for 30 min at 4°C. The cells were then fixed and permeabilised using the Fixation/Permeabilization intracellular staining kit according to the manufacturer's protocol (eBioscience). After fixation and permeabilisation, cells were incubated with Percp-cy5.5-anti-FOXP3 (eBioscience) and PE-anti-CTLA-4 (BD Bioscience) Abs. Data were acquired with a FACSCalibur flow cytometer (BD Bioscience) and analysed with FlowJo software (Tree Star). cells/well) and anti-CD3 (1 μg/ml). The T cell-depleted spleen cells were briefly treated with mitomycin C and used as APCs. After 3 days, responder T cell proliferation with or without Foxp3 + T cells was assessed using flow cytometry based on the dilution of the CFSE dye.
Suppression assays in vitro
FOXP3 Treg-specific demethylated region (TSDR) DNA methylation analysis
Cells for this series of experiments were from normal male donor peripheral blood to avoid the problems with interpretation from X-chromosomal inactivation of one FOXP3 allele in the methylation analysis. FACS-sorted naive and CD62L + central memory CD4
+ cells were stimulated for 5 days in the presence of IL-2 (100 U/ml) with or without TGF-β. Sorted CD4 + CD25 high Tregs were stimulated for 5 days in the presence of IL-2 (300 U/ml) as a control. Genomic DNA of cultured cells was extracted by using the EasyPure TM Genomic DNA kit (TransGen Biotech) according to the manufacturer's protocol for cultured mammalian cells. Bisulfite conversion of genomic DNA was performed by the EZ DNA Methylation-Gold™ Kit (ZYMO RESEARCH) according to the manufacturer's instructions. DNA was then subjected to PCR with the following TSDR-primers (5' to 3' direction): forward -TGTTTGGGGGTAGAGGATTT and reverse -TATCACCCCACCTAAACCAA [20] . PCR was performed in a final volume of 25 μl containing 1x PCR Buffer, 1.25 U Taq DNA polymerase (TaKaRa, LA Taq Hot Start Version), 200 mM dNTPs, 100 pmol each of forward and reverse primers, and 2 μl of bisulfite-treated genomic DNA at 95°C for 10 min and 40 cycles of 95°C for 1 min, 55°C for 45 sec and 72°C for 1 min with a final extension step of 10 min at 72°C. PCR products were purified using the Wizard SV Gel and PCR Clean-Up System (Promega). The purified PCR products were then cloned into the pMD19-T vector (TaKaRa), and 15 individual clones from each sample were cycle sequenced by the ABI 3730 genetic analyzer (Applied Biosystems). DNA methylation analysis and diagram generation were performed by BiQ Analyzer [21] .
Statistical analysis
GraphPad Prism 5.00 software (GraphPad) was used to compare the difference among different groups by using the unpaired t test, when values at p<0.05 were considered as significant.
Results
The Table S1 . We first gated on CD4 + cells from the PBMCs ( Figure 1A ) and found that the proportion of CD4 + T cells induced in vivo. We purified CD4 + naive T cells from human PBMCs and induced CD4 + Foxp3 + by T-cell receptor (TCR) activation in vitro. We found that the CD4 + naive T cells that were activated either by TCR stimulation alone or together with TGF-β and IL-2 rarely co-expressed CD45RO and Foxp3 ( Figure 1E ). When we analysed the expression of CD45RA, we found that naive CD4 + T cells showed no CD45RA expression under stimulation in vitro ( Figure S1 ).
The above results collectively show that CD4 + T cells, we showed that TGF-β-mediated Foxp3 expression was significantly higher in CD4 + naive T cells than in CD4 + memory T cells. However, a small undefined population of CD4 + memory T cells was induced to express Foxp3 ( Figure 2B ).
Treg express several inhibitory molecules, such as CTLA-4, PD-1, and PD-L1, which are potentially necessary for their suppressive functions [24] [25] [26] . We analysed the expression of these molecules by flow cytometry before and after stimulation with TGF-β. Prior to stimulation, the expression levels of membrane CTLA-4 and PD-L1 were not significantly different between CD4
+ naive and memory T cells. However, PD-1 was expressed in CD4 + memory but not naive T cells. In addition, both CD4 + naive and memory T cells expressed intracellular CTLA-4, but the expression level was significantly higher in memory T cells ( Figure 2C,E) . After stimulation, the CD4 + memory T cells cultured with TGF-β expressed higher levels of membrane CTLA-4 than CD4 + naive T cells. The total cytosolic and membrane CTLA-4 expression levels were similar between the cell populations. The expression levels of PD-L1 and PD-1 were also similar between the two cell populations ( Figure  2D,F) .
The above results showed that, although CD4 + memory T cells were resistant to TGF-β-mediated Foxp3 expression, they expressed higher levels of membrane CTLA-4 than CD4 + naive T cells. The high level of membrane CTLA-4 expression in memory CD4
+ T cells that is observed upon Foxp3 induction -(effector memory, T em ) T cells and compared their responsiveness to TGF-β stimulation. The results showed that the differentiation efficiency of central memory T cells was higher than that of effector memory T cells ( Figure 3A) . Although the CD4 + central memory T cells were induced into Foxp3 + T cells more efficiently than the effector memory T cells, the rate of differentiation was still lower than that of CD4 + naive T cells. This led us to perform a more detailed surface marker analysis of the CD4 + central memory T cell pool. This analysis identified a group of cells that were doubly positive for CD62L and CCR7 and had a similar surface expression phenotype to CD4 + naive T cells ( Figure 3B ). Because CD4 + CD45RO -T cells express a high level of CD45RA ( Figure S2 ), we considered CD4 + CD45RO -T cells to be CD4 + CD45RA + naive T cells. We then isolated these groups of CD4 + memory T cells based on CD62L and CCR7 expression and examined their response to TGF-β induction. As expected, the differentiation efficiency of CD4 Figure 5A ) [10] . To investigate the function of the induced tumours [4, [29] [30] [31] [32] [33] . However, the detailed mechanisms underlying their origin and differentiation are unknown. Although CD4 + Foxp3 -naive T cells can be converted to iTreg by TGF-β, the ability of CD4 + memory T cells to differentiate into iTreg remains controversial. Some studies have reported that human skin-derived CD4 + memory T cells and mouse antigen-specific Th2 memory cells can be successfully converted to CD4 + Foxp3 + T cells in vitro [14, 15] , and our data support this observation.
In the peripheral blood of chronic HBV-infected patients, the percentage of CD4 + Foxp3 + T cells was significantly higher than in healthy controls, and the increased numbers of CD4 + T cells. In the case of HBV, higher levels of Treg have been described [34] . It is well known that not all human Foxp3 + cells are Treg, particularly under conditions of chronic cell activation, such as a viral infection, where there may be a higher proportion of effector T cells that transiently upregulate Foxp3 [35, 36] . However, the frequency of total CD4 + CD25
+ T cells was not significantly different between chronic HBV-infected patients and healthy controls [37] . In addition, HBV-infected patients in the inactive (IN) phase have low HBV DNA levels (<2000 IU/ml) and normal ALT levels with minimal or absent hepatic inflammation [38, 39] . This indicates that CD4 + T cells are not activated in chronic HBV-infected patients in the inactive (IN) phase. Thus, the incremental CD4 + CD25 -non-regulatory T cells, Foxp3 is considered to be the definitive marker of mouse nTreg, iTreg generated in the periphery in vivo, and iTreg generated in vitro in the presence of TGF-β [40] . In contrast, several studies have claimed that this is not the case in humans. They suggest that human CD4 + CD25 -T effector cells activated through TCR stimulation alone with anti-CD3 and anti-CD28 show transiently upregulated Foxp3 expression and demonstrate that this Foxp3 expression correlates with neither anergy nor suppressive function [35, [41] [42] [43] [44] [45] . In addition to confirming these previous studies, our results shown in Figure 2A and Figure 3A reveal new aspects involving Foxp3 expression. Consistent with previous studies, upon stimulation with anti-CD3 and anti-CD28, the memory CD4 + CD25 -T cells in our study transiently upregulated their expression of Foxp3, and a dramatic increase in the percentage of Foxp3 + cells was observed, with up to 18% of the memory CD4 + T cells expressing Foxp3 on day 3 ( Figure  2A ). 
CD25
-T cells stimulated in the presence of TGF-β also showed an increase in Foxp3 expression compared with those stimulated without TGF-β (Figure 2A and Figure 3A + T cells. However, the detailed mechanism of this differentiation is still unclear and requires further study. We hypothesise that it is related to the intrinsic constraints of the cells but not due to their similarity to the CD4 + naive T-cell phenotype. Human CD4 + memory T cells are not a uniform population, and they can be divided into the two functionally distinct subsets of CCR7 + central memory and CCR7 -effector memory T cells [49] . There are significant differences between these two subsets of cells, as illustrated by their heterogeneity and effector functions, among other factors [50, 51] . Of note, CD4 + central memory and effector memory cells have different capacities to produce cytokines. Upon activation, CD4
+ effector memory cells secrete high levels of IL-4 and IFN-γ, which are not produced by activated CD4 + central memory cells or CD4 + naive T cells [49] . Additionally, it is widely accepted that IL-4 and IFN-γ are the major cytokines involved in the inhibition of TGF-β-induced Foxp3 expression in CD4 +
-T cells [9] [10] [11] 52] . Therefore, differences in cytokine secretion could potentially explain why Figure S1 . Expression of CD45RA in the samples shown in Figure 1E . Naive CD4 + T cells were sorted from adult peripheral blood using FACS, and the cells were activated with plate-bound anti-CD3 (5 μg/ml) and soluble anti-CD28 (1 μg/ml) in the absence or presence of TGF-β (5 ng/ml) and IL-2 (100 UI/ml) for 5 days. The cells were then collected and analysed by flow cytometry to evaluate the expression of 
Supporting Information
